Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 1-Chloro-2,4-dinitronaphthalene

1-Chloro-2,4-dinitronaphthalene

1-Chloro-2,4-dinitronaphthalene structure

1-Chloro-2,4-dinitronaphthalene 

structure
  • CAS No:

    2401-85-6

  • Formula:

    C10H5ClN2O4

  • Chemical Name:

    1-Chloro-2,4-dinitronaphthalene

  • Synonyms:

    Naphthalene,1-chloro-2,4-dinitro-;1-Chloro-2,4-dinitronaphthalene;2,4-Dinitro-1-naphthyl chloride;2,4-Dinitro-1-chloronaphthalene;2,4-Dinitrochloronaphthalene

1-Chloro-2,4-dinitronaphthalene Basic Attributes

252.61

252.61

8T00EW178R

DTXSID1062382

Yellow needles

2904909090

Characteristics

91.6

4.35600

1.586g/cm3

146.5 °C

404.3ºC at 760mmHg

198.3ºC

1.708

1mg/L(25 ºC)

2.24E-06mmHg at 25°C

Safety Information

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Drug Information

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. Administer activated charcoal ... . /Naphthalene and Related Compounds/|Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious. Start an IV with lactated Ringer's. Adequate hydration must be maintained to prevent renal failure secondary to myoglobinuria unless signs of cerebral or pulmonary edema are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Administer 1% solution methylene blue if patient is symptomatic with severe hypoxia, cyanosis, and cardiac compromise not responding to oxygen. ... . Treat seizures with diazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Naphthalene and related compounds/|Maintain an open air way and assist ventilation if necessary. Treat coma and seizures if they occur. Treat hemolysis and resulting hemoglobinuria if they occur by intravenous hydration and urinary alkalinization. There is no specific antidote. Administer activated charcoal if available. Do not induce vomiting, because of the risk of lethargy and seizures. Do not administer milk, fats or oils, which may enhance absorption /Naphthalene/

1-Chloro-2,4-dinitronaphthalene Use and Manufacturing

Naphthalene, 1-chloro-2,4-dinitro-: INACTIVE

Computed Properties

Molecular Weight:252.61
XLogP3:3.5
Hydrogen Bond Acceptor Count:4
Exact Mass:251.9937843
Monoisotopic Mass:251.9937843
Topological Polar Surface Area:91.6
Heavy Atom Count:17
Complexity:327
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.